The car turned a corner, passed by the main gate of the Red Building, and arrived at the Shennong Hotel.
This is an earlier five-star hotel.
Liu Muqiao arranged a private room.
Zhao Yilin and Zou Qingxiang were arranged to live in the same room.
Su Yajuan lives with an unknown female expert.
Due to the large number of participants, everything is arranged by the organizing committee.
Liu Muqiao had just moved in when someone came to visit him.
Old acquaintance!
Professor Smith!
Professor of Neurology at Hopkins Hospital.
They already knew each other two years ago.
"How is the nerve regeneration factor you are studying?" Liu Miqiao couldn't wait to ask as soon as they met.
"It failed and serious side effects occurred."
Smith is not shy either. He has a very good personal relationship with Liu Miqiao. In front of him, there is no need to hide, let alone lie.
"Oh. What a pity, what kind of side effects are they?"
"Induced glioblastoma."
"Oh, then there's nothing we can do."
"Your Huatuo Regeneration Pills are very effective."
"It's okay."
"With such a medicine, you should be a billionaire, right?"
"Billionaire? Morning!" Liu Maqiao laughed.
He rarely considers this issue. Since many countries are rejecting traditional Chinese medicine, Huatuo Regeneration Pills are not marketed around the world
Coupled with the limited production capacity, Liu Miqiao and the others did not sell it to the world, so the sales volume was not particularly large.
Last year, Hua Tuo’s regeneration pills’ sales were 16.7 billion.
It's not time to pay dividends yet, and we are continuing to expand production capacity.
"Professor, in which aspect are you going to share your results with us this time?" Liu Miqiao asked.
"We have made some progress in Alzheimer's disease. This time, we want to announce a result." Professor Smith raised his head proudly.
Liu Muqiao was surprised.
Because Liu Muqiao is also studying this thing.
Last time, he obtained the real dragon bone, which is useful in this aspect, and the clinical effect was very good. Since then, he has been analyzing the ingredients in the laboratory and studying its molecular structure.
Because this is an important achievement, Liu Miqiao has kept silent.
Now, Professor Smith, they announced the results first, which is troublesome.
Liu Muqiao was vaguely worried, might the secret be leaked?
It's hard to say.
In the scientific research community, stealing information from each other is common.
Liu Muqiao's laboratory is open. Although important scientific research projects also have confidentiality measures, it is difficult to say that there are no spies.
It can be said that Liu Miqiao's laboratory has the most complex personnel structure, with talents from various countries, especially Mark and Tom, who are American scientists themselves.
When Liu Muqiao thought of this, his heart became heavy.
He values scientific research results in the treatment of Alzheimer's disease more seriously than Huatuo Zaisheng Pills for stroke treatment.
Liu Muqiao did not encrypt the prescription for Huatuo Regeneration Pills, but he did encrypt the prescription for the drugs used to treat Alzheimer’s disease.
He originally planned to follow the Western medicine method to research the effective ingredients, then apply for a patent, and then announce his success to the world.
Did Johns Hopkins Hospital get the first step?
When Smith saw Liu Muqiao's expression changing slightly, he smiled and said, "Brother, how about it? You must be lagging behind in this regard, right?"
Liu Muqiao smiled awkwardly.
After chatting for a while, Smith left.
As soon as he left, Liu Muqiao made a phone call to Jiang Wei and asked her to quickly investigate whether there was any possibility of the laboratory being kept secret.
Unexpectedly, only half an hour later, Jiang Wei called and said that a confidentiality incident had indeed occurred in the laboratory, and the safe had been tampered with.
Mark and Tom are organizing people from the Security Department to investigate further.
Another half an hour later, I got a call. The data was not lost, but the safe had been opened. In other words, the confidentiality was definitely compromised.
There are an estimated 13 scientific research results involved, among which the most significant result is the analysis of drug ingredients for the treatment of Alzheimer's disease.
"Hurry up and apply for a patent in China! Encrypt the results and send them to my email. I will announce the results at the conference tomorrow!"
Liu Muqiao said anxiously.
After a while, Liu Muqiao received the email. He called Zhao Yilin, Zou Qingxiang and Su Yajuan over and told them about the matter.
Several people were stunned for a few minutes. They knew that this kind of thing was extraordinary.
Drugs for treating Alzheimer's disease are epoch-making drugs, similar to penicillin. If the effect can reach more than 80%, the probability of winning the Nobel Prize is very high.
Liu Muqiao arranged for Zou Qingxiang and Su Yajuan to print materials and distribute them at the conference tomorrow. He and Zhao Yilin asked the leaders of the organizing committee to coordinate the agenda of tomorrow's meeting.
"This is a bit interesting. Tomorrow afternoon, Professor Smith from Hopkins University will also announce the results, and you will also announce. Is this good news for Alzheimer's patients, or is it a hand-to-hand battle between your two hospitals?" Domestic Organizing Committee
The director is Xiao Bo, who is the chief director and vice president of the Neurology Department of Xiangya Hospital.
Of course he knew Liu Muqiao's intention, which was to release the results before others. As a Chinese, of course he supported it.
The organizing committee has approved this.
But there are still problems.
Neuropsychiatry is divided into many branches, dozens of major branches and hundreds of smaller branches. Each scholar has his own expertise.
They all work in neurology, but each expert is good at diagnosing and treating only a few diseases.
After the opening ceremony tomorrow morning, Liu Muqiao was supposed to give a report: "Minimally invasive and traditional Chinese medicine treatment of stroke."
Now it suddenly changes to announcing the treatment of Alzheimer's disease, which is completely wrong. I don't know what I want to hear, but I hear what I don't want to hear.
Therefore, it stands to reason that today we should be informed at short notice that tomorrow’s agenda has been changed.
Liu Muqiao stopped him.
He must attack suddenly and get ahead of Professor Smith.
Time passed little by little.
It was already 12 o'clock in the evening when Su Yajuan and Zou Qingxiang brought the materials back.
That night, Liu Muqiao was extremely nervous. He didn't even hibernate. He had many dreams and nightmares throughout the night.
Liu Muqiao got up very early.
He didn't go to morning exercises and guarded these materials.
He was very worried that Smith and the others knew that they had changed their agenda. He was not relieved until he and Smith came face to face during breakfast.
Smith greeted Liu Miqiao warmly.
He is in a good mood.
Of course Liu Muqiao knew the reason why they were in a good mood. He had an earth-shattering scientific research result in his hands. How could he not be excited?
It can be said that the clinical value of drugs for treating Alzheimer's disease is greater than that of Huatuo Zaizao Pills.
Alzheimer's disease is an extremely frightening degenerative disease. When it reaches its advanced stage, not to mention living independently, even caregivers will have a headache.
If there is a way to delay or treat this disease, the benefits to society will be huge.
"Dr. Liu, I will listen to your report throughout. I think you will benefit a lot." Professor Smith said to Liu Muqiao with great respect.
This chapter has been completed!